REVERSE VENTRICULAR REMODELING IN PATIENTS WITH VALVULAR HEART DISEASE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY

Patients with non-ischemic cardiomyopathy are largely regarded to derive superior response to cardiac resynchronization therapy (CRT)compared to ischemic patients. Patients with non-ischemic cardiomyopathy (NICM), however, are heterogeneous with multiple different myocardial substrates. We sought to